Oct 30, 2014 at 17:05 | Source: CNBC-TV18
Commenting the markets move, Raamdeo Agrawal, joint managing director, Motilal Oswal, said the recent selling for foreign investors had abated and this had pushed markets higher and that one was likely to see fresh highs ahead.
Oct 30, 2014 at 12:13 | Source: CNBC-TV18
Pankaj Jain of Sunteck Wealthmax recommends buying Wockhardt for a target price of Rs 809 and Pennar Industries for a target price of Rs 64.
Oct 30, 2014 at 10:23 | Source: CNBC-TV18
Manoj Murlidharan of Religare Securities recommends buying Cipla and feels that Reliance Industries may move up by 7 percent.
Oct 29, 2014 at 13:39 | Source: CNBC-TV18
Satish Ramanathan, market analyst has a positive view on pharma, healthcare and agricultural sector.
Oct 29, 2014 at 13:11 | Source: Moneycontrol.com
Sun Pharmaceutical Industries Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 13, 2014, inter alia, to consider and take on record the un-audited financial results of the Company for the second quarter ended September 30, 2014 (Q2).
Oct 29, 2014 at 11:46 | Source: Moneycontrol.com
Auto stocks like Tata Motors, Hero Motocorp, M&M, TVS Motor and Eicher Motors will be getting astrological support, says Satish Gupta of Astrostocktips.
Oct 29, 2014 at 11:19 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com advises buying Ranbaxy Laboratories at current levels.
Oct 29, 2014 at 10:58 | Source: CNBC-TV18
Prakash Agarwal, Equity Analyst at CIMB is of the view that one may hold Sun Pharmaceutical Industries.
Oct 29, 2014 at 09:05 | Source: CNBC-TV18
Prakash Agarwal, Equity Analyst, CIMB has a hold rating on Ranbaxy with target price of Rs 630/share.
Oct 28, 2014 at 14:02 | Source: Moneycontrol.com
The company reported consolidated net profit of Rs 478 crore during the quarter as against loss of Rs 454 crore in the year-ago period.